Bio Pharma Dive

AUGUST 23, 2021

The decision, which follows the recommendation of a data monitoring committee, is yet another setback in the search for more treatments for the neurological disease.

Drug Trials 258

Drug Trials Trials Drugs 258

Bio Pharma Dive

DECEMBER 9, 2023

Study results disclosed at the American Society of Hematology meeting Saturday suggested potential for cell therapy in lupus and pointed out drug trial limitations.

Drug Trials 317

Drug Trials Trials Drugs 317

Bio Pharma Dive

OCTOBER 31, 2022

Bringing more diversity to clinical trials is a slow process and it takes time to get right. Learn how Worldwide Clinical Trials can diversify the reach of your orphan drug trial.

Clinical Trials 317

Clinical Trials Clinical Trials Drug Trials Trials 317

pharmaphorum

JUNE 26, 2023

FDA sets out its thinking on psychedelic drug trials Phil.Taylor Mon, 26/06/2023 - 07:15 Bookmark this

Drug Trials 105

Drug Trials Trials Drugs 105

pharmaphorum

AUGUST 17, 2023

Abcuro raises $155m for KLRG1 drug trial Phil.Taylor Thu, 17/08/2023 - 14:54 Bookmark this

Drug Trials 97

Drug Trials Trials Drugs 97

Bio Pharma Dive

JULY 28, 2022

Important data from the APOLLO study of the biotech's drug Onpattro are due before the end of August, Alnylam said Thursday.

Drug Trials 169

Drug Trials Drugs Trials 169

Pharma Times

AUGUST 22, 2024

200,000 people in the UK have what is considered a ‘hidden’ lung condition

Drug Trials 158

Drug Trials Trials Drugs Research 158

Pharma Times

DECEMBER 4, 2020

LYT-100 will be evaluated in patients with persistent symptoms caused by COVID-19

Drug Trials 159

Drug Trials Trials Drugs 159

Bio Pharma Dive

DECEMBER 6, 2022

The decision not to run a Phase 3 trial of their medicine is the latest fallout from U.S. regulators’ recent moves to closely evaluate a class of drugs known as PI3 kinase inhibitors.

Drug Trials 161

Drug Trials Trials Drugs Regulation 161

Pharmaceutical Technology

OCTOBER 14, 2024

Digital assessment technologies continue to hold the potential to revolutionise pro-cognitive trials in schizophrenia.

Drug Trials 130

Drug Trials Trials Drugs 130

Bio Pharma Dive

MAY 24, 2022

The biotech plans to seek FDA approval for its soft-tissue tumor treatment after positive study results. But investors still sent the stock down by nearly 10%.

Drug Trials 130

Drug Trials FDA Approval Trials Drugs 130

pharmaphorum

MAY 19, 2022

.” Empatica’s range of wearables are well-established tools for studies in the pharma and healthcare industry, and have been used by many drug and medical device developers, including Sanofi, Roche, Novartis, Abbott, Bristol-Myers Squibb, and Johnson & Johnson.

Drug Trials 105

Drug Trials Trials Drugs Development 105

Pharma Times

SEPTEMBER 13, 2024

Innovative immunotherapy drug HTL0039732 shows potential in trials

Trials 137

Trials Drug Trials Drugs Research 137

pharmaphorum

JANUARY 25, 2021

Data in second line was “robust” and merits further trials, the company said in an update earlier this month, and the company is continuing to gather data from a part of the study testing the drug in first line NSCLC. The post GSK suffers another R&D setback, axing ulcerative colitis drug trial appeared first on.

Drug Trials 103

Drug Trials Trials Drugs Licensing 103

Pharmaceutical Technology

APRIL 16, 2024

The US FDA placed the clinical hold based on the preclinical data that showed that Neumora’s NMRA-266 triggered convulsions in rabbits.

Drug Trials 130

Drug Trials Trials Drugs 130

pharmaphorum

OCTOBER 27, 2020

Merimepodib is the subsidiary’s primary asset, and the biotech now says it is to offers to acquire or license the drug. The post BioSig abandons COVID-19 drug trial on safety concerns appeared first on. Image credit: Rocky Mountain Labs/NIH.

Drug Trials 98

Drug Trials Trials Drugs Contract Manufacturing 98

Bio Pharma Dive

JULY 17, 2023

The results come about two years after negative findings from an earlier phase of the study, and position the company to seek an approval in transthyretin amyloidosis cardiomyopathy.

Drug Trials 130

Drug Trials Trials Drugs 130

pharmaphorum

MAY 7, 2021

The post Small Pharma stock market launch funds DMT-based depression drug trial appeared first on. “Given most other psychedelics focused companies have only been formed in the last 2 years, we believe our focus on IP since inception in 2015 gives us the potential to build a robust portfolio of valuable assets,” he added.

Drug Trials 98

Drug Trials Trials Marketing Drugs 98

pharmaphorum

DECEMBER 28, 2023

Cytokinetics rises on report that its aficamten drug improved symptoms in people with rare disease obstructive hypertrophic cardiomyopathy

Drug Trials 103

Drug Trials Drugs Trials 103

Scienmag

JANUARY 19, 2022

New research suggests manufacturers of newly developed antidepressant drugs have become more forthcoming about clinical trials that don’t pan out.

Trials 98

Trials Drug Trials Drugs Clinical Trials 98

BioPharma Reporter

OCTOBER 4, 2022

Kibow Biotech is celebrating its 25th anniversary as the company pivots toward developing a drug based on its proprietary probiotic strains that benefit kidney disease suffers.

Drug Trials 98

Drug Trials Drugs Trials Development 98

Scienmag

DECEMBER 20, 2021

A clinical trial in which two test drugs failed to help patients with mild COVID-19 nevertheless had a silver lining: It proved the viability of a study model in which a medication’s potential arrhythmic side effects are safely, effectively monitored without the participants ever setting foot in a hospital or clinic.

Drug Trials 98

Drug Trials Trials Drugs Clinical Trials 98

STAT News

MARCH 29, 2023

Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them young women of color, are waiting — just three lupus drugs have been approved by the Food and Drug Administration in six decades. A key partnership is looking to change that.  

Drug Trials 109

Drug Trials Trials Drugs Clinical Trials 109

BioSpace

JANUARY 28, 2021

Food and Drug Administration (FDA) has cleared an Investigational New Drug application that will allow Boston-based Vertex Pharmaceuticals to proceed with a clinical trial of its investigational stem cell-derived, fully differentiated pancreatic islet cell treatment for type 1 diabetes (.

Drug Trials 111

Drug Trials Trials Drugs Clinical Trials 111

Medical Xpress

DECEMBER 29, 2022

A new drug designed to ward off Alzheimer's is being tested at more than 100 sites around the world, including the University of Pennsylvania.

Drug Trials 95

Drug Trials Drugs Trials Research 95

BioSpace

OCTOBER 11, 2020

was convicted on 47 counts of fraud and drug related charges on Oct. A 41-year-old man from Richland, Wash. 1, according to the U.S. Justice Department’s Eastern District of Washington.

Drug Trials 99

Drug Trials Drugs Trials 99

Outsourcing Pharma

APRIL 6, 2023

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Drug Trials 98

Drug Trials Trials Clinical Trials Clinical Trials 98

BioSpace

FEBRUARY 15, 2021

According to a statement made by Cortexyme, the partial hold was placed on the development program for atuzaginstat after an FDA review of the trial data identified hepatic adverse events.

Drug Trials 88

Drug Trials Trials Drugs Development 88

pharmaphorum

FEBRUARY 21, 2024

Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.

Clinical Research 129

Clinical Research Trials Research Drug Trials 129

BioPharma Reporter

JULY 11, 2024

Amid a period of clinical holds and legal tangles, the US antibody specialist CytoDyn has reached a settlement to resolve legal disputes with its former contract research organization (CRO) Amarex Clinical Research.

Antibody 98

Antibody Drug Trials Clinical Research Trials 98

BioPharma Reporter

JULY 4, 2023

Sosei Heptares has dosed the first subject in a phase 1 trial evaluating HTLâ149, a first-in-class GPR52 agonist, which represents a novel mechanism of action for the treatment of schizophrenia and related neurological diseases.

Drug Trials 78

Drug Trials Trials Drugs Development 78

STAT News

SEPTEMBER 22, 2022

Hello, everyone, and how are you today? A dank cloudy cover greeted us this morning, but we are ignoring the gloom by keeping busy. After all, there is much to be done. There are deadlines to meet, a variety of reading material to digest, and calls to make. We trust you can relate.

Drug Trials 96

Drug Trials Trials Drugs 96

World of DTC Marketing

APRIL 20, 2022

The feedback suggests that pharma has significant opportunities to get closer to HCPs via more transparency about drug trials and data. The most likely reason to visit a pharma website for HCPs is to download the product label. Will they transform their HCP marketing or stick to dated models?

Marketing 264

Marketing Drug Trials Drugs Sales 264

BioSpace

OCTOBER 19, 2021

?SURPASS-4 is part of the Phase III trial evaluating tirzepatide as a possible treatment for type 2 diabetes.

Drug Trials 79

Drug Trials Trials Drugs 79

Scienmag

JUNE 15, 2022

A novel staging framework that assesses the progression of Huntington’s disease (HD), similar to the way cancer is staged 0 to 4, has been developed by UCL scientists as part of an international consortium; this ‘significant’ step paves the way for clinical trials of drugs in the earliest phase of disease.

Drug Trials 75

Drug Trials Trials Drugs Clinical Trials 75

STAT News

MARCH 27, 2023

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online meetings, phone calls, and deadlines has predictably returned. But you knew this would happen, yes? After all, the world, such as it is, keeps spinning.

Trials 97

Trials Drug Trials Drugs Clinical Trials 97

pharmaphorum

FEBRUARY 10, 2025

Shares in Pliant plunged after the US biotech revealed that a safety signal led it to pause a trial of its idiopathic pulmonary fibrosis drug.

Drug Trials 66

Drug Trials Trials Drugs 66